-
IDEAYA Biosciences and Boston Children's Hospital Collaborate
Post on 1/12/20
-
Oramed Pharmaceuticals Issues Letter to Shareholders
Post on 1/9/20
-
Omnicom Public Relations Group Forms Strategic Alliance with LaVoieHealthScience
Post on 1/9/20
-
Sebacia Announces Leadership Update and Acquisition of Silver Photoparticle Technology Assets from Sienna Biopharmaceuticals
Post on 1/9/20
-
Merck's Blockbuster Drug Wins Key New FDA Approval
Post on 1/9/20
-
EHE Health Partners with Cedar Gate Technologies
Post on 1/8/20
-
Prisma Health Renews Partnership With Prudential
Post on 1/8/20
-
Merck's Keytruda Misses an Important Lung Cancer Goal
Post on 1/8/20
-
Tyme Technologies and Eagle Pharmaceuticals Announce Strategic Collaboration
Post on 1/7/20
-
Bristol-Myers Squibb Completes Divestment of Manufacturing Facility in Anagni, Italy
Post on 1/7/20
-
Bioasis Announces Shares for Debt Transaction
Post on 1/6/20
-
OWYN Announces Growth Investment Led by PowerPlant Ventures
Post on 1/6/20
-
Slayback Pharma Announces Investment of $50M by The Everstone Group
Post on 1/6/20
-
Merck Establishes Strategic Oncology Collaboration with Taiho and Astex
Post on 1/6/20
-
Johnson & Johnson: The Pharma Giant That Continues To Grow
Post on 1/6/20
-
Is Johnson & Johnson Stock a Buy?
Post on 1/6/20
-
Is Cigna's Stock a Buy?
Post on 1/6/20
-
Here's Why Bristol-Myers Squibb Jumped 12.7% in December
Post on 1/6/20
-
AzurRx BioPharma Appoints Daniel Schneiderman as CFO
Post on 1/5/20
-
Johnson & Johnson: Litigation Risk Discounting Shares Relative To Market
Post on 1/3/20
-
Better Buy: Abbott Laboratories vs. Pfizer
Post on 1/2/20
-
Cigna: The Health Services Powerhouse (Part 2)
Post on 1/2/20
-
If You Invested $10,000 in Johnson & Johnson's IPO, This Is How Much Money You'd Have Now
Post on 1/2/20
-
Pfizer Just Raised Its Dividend: Is Now a Good Time to Buy?
Post on 1/2/20
-
Does Johnson & Johnson’s Dividend Make It A Buy?
Post on 1/2/20